Effect of estrogen on the metabolism of cortisol and cortisone in the baboon fetus at midgestation.
To determine whether the metabolism of cortisol (F) and cortisone (E) in the baboon fetus is regulated by estrogen, fetal interconversion of F/E was measured at midgestation after an experimental increase in placental estradiol (E2) production. Six baboons (Papio anubis) received increasing numbers of androstenedione implants (50 mg) inserted s.c. at 8-day intervals between Days 70 and 100 of gestation (term = Day 184) to elevate the production of estrogen; controls (N = 8) received no treatment. On Day 100 of gestation, each animal was anesthetized with ketamine:halothane/nitrous oxide, the fetus was exteriorized and [3H] F/[14C] E was infused via a fetal femoral vein for 70 min. Blood samples were then obtained from the contralateral fetal femoral vein, the umbilical vein/artery, and a maternal saphenous vein. After purification of F and E, the metabolic clearance rate (MCR), peripheral interconversion, and placental extraction of F and E were calculated. Maternal serum E2 concentrations (ng/ml; mean +/- SE) between Days 80 and 100 of gestation were greater (p less than 0.01) in androstenedione-treated baboons (2.2 +/- 0.2) than in untreated controls (1.2 +/- 0.1). Although the MCR of F was similar in control (5.2 +/- 0.3 1/day) and treated (7.7 +/- 1.0 1/day) animals, the MCR of E (13.5 +/- 2.0 1/day) was increased (25.8 +/- 2.5 1/day; p less than 0.05) by androstenedione treatment. Placental extraction of F (59 +/- 9%) was lower (p less than 0.01) than that of E (82 +/- 5%) in untreated baboons and was not affected by androstenedione treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
Waddell
B J
BJ
Department of Physiology, Eastern Virginia Medical School, Norfolk 23501.
Albrecht
E D
ED
Pepe
G J
GJ
D000735:Androstenedione / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001784:Blood Gas Analysis / Q000662:veterinary; D001835:Body Weight; D003348:Cortisone / Q000378:metabolism*; D004343:Drug Implants; D004958:Estradiol / Q000097:blood; D004967:Estrogens / Q000502:physiology*; D005260:Female; D005333:Fetus / Q000378:metabolism*; D006339:Heart Rate; D006854:Hydrocortisone / Q000378:metabolism*; D010084:Oxidation-Reduction; D010215:Papio / Q000378:metabolism*; D010920:Placenta / Q000187:drug effects / Q000378:metabolism; D011247:Pregnancy
D004343:Drug Implants; D004967:Estrogens; D000735:Androstenedione; D004958:Estradiol; D003348:Cortisone; D006854:Hydrocortisone